Drug safety: Further actions needed to improve fda’s postmarket decision-making process
GAO_drug_safety_507.pdf
|
172.8 kB
May 9, 2007
GAO report found that FDA lacked clear and effective processes for making decisions about, and providing management oversight of, postmarket drug safety issues.